Profile data is unavailable for this security.
About the company
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
- Revenue in USD (TTM)171.75bn
- Net income in USD6.24bn
- Incorporated2001
- Employees104.90k
- LocationElevance Health Inc220 Virginia AvenueINDIANAPOLIS 46204United StatesUSA
- Phone+1 (317) 488-6000
- Websitehttps://www.elevancehealth.com/
Mergers & acquisitions
Acquired company | ELV:NYQ since announced | Transaction value |
---|---|---|
Paragon Healthcare Inc | 9.39% | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 20.22m | 8.69% |
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 11.56m | 4.97% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 11.45m | 4.92% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 10.41m | 4.47% |
Wellington Management Co. LLPas of 31 Dec 2023 | 5.91m | 2.54% |
Geode Capital Management LLCas of 31 Dec 2023 | 4.52m | 1.94% |
Sanders Capital LLCas of 31 Dec 2023 | 4.46m | 1.92% |
Capital Research & Management Co. (International Investors)as of 31 Dec 2023 | 3.37m | 1.45% |
AllianceBernstein LPas of 31 Dec 2023 | 3.31m | 1.42% |
Columbia Management Investment Advisers LLCas of 31 Dec 2023 | 3.12m | 1.34% |